![Activist Fights Tick Up, Along With Settlements to Head Them Off](/i/c/35db2351-f559-ddf1-5e8e-e3572bd14193.webp)
Activist Fights Tick Up, Along With Settlements to Head Them Off
The first proxy season after a key US rule change was expected to rock the shareholder activism world.
2023-07-10 20:56
![NATO Summit, Ukraine’s Arms Plan: Your Sunday US Briefing](/i/c/7a4ed168-e8f8-b9bb-3911-5c5359e89c39.webp)
NATO Summit, Ukraine’s Arms Plan: Your Sunday US Briefing
Hello from Washington, where the dog days of summer have arrived and the unbearable humidity is ensuring DC
2023-07-09 23:51
![How a Japanese Drugmaker Clinched Win Over Alzheimer’s](/i/c/80e9deea-628a-537f-7104-e8d946fcf056.webp)
How a Japanese Drugmaker Clinched Win Over Alzheimer’s
(This story was originally published Sept. 29. On Thursday, the US Food and Drug Administration granted full approval
2023-07-07 08:57
![Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy](/i/c/30b3df02-1e66-d166-e883-03a05eed03e8.webp)
Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy
Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from US regulators, a move expected to widen access to
2023-07-07 05:29
![Eisai, Biogen Clinch FDA Advisers’ Support for Alzheimer’s Drug](/i/c/0feb1972-25cd-5746-416f-d99646ea34eb.webp)
Eisai, Biogen Clinch FDA Advisers’ Support for Alzheimer’s Drug
Eisai Co.’s Alzheimer’s disease drug developed with Biogen Inc. gained support from advisers to US regulators, paving the
2023-06-12 09:22
![Drug Companies Are Minting Billions on Unproven Treatments With FDA Shortcut](/i/c/e449a9d7-0a33-8394-db99-396d81c21e03.webp)
Drug Companies Are Minting Billions on Unproven Treatments With FDA Shortcut
When Exondys 51 was approved to treat Duchenne muscular dystrophy, a deadly disease that puts kids in wheelchairs
2023-05-15 07:23